$6.55 million in sales, 3 million cost of sales.
That, my friend, is a margin of more than 50 percent.
And that is going to serve this company very very well as sales continue to move into the seven and eight figure range.
The focus here should be on the exponential sales growth even before OTC kicked in. And now that it is here, look out!
What happened to the “selling worthless Alibaba” argument? Gone. What happened to the “No sales” argument? Gone.
This is absolutely moving in the right direction. $INND